Home ›
Companies in Liquidation ›
Eagle Genomics Limited Is Eagle Genomics Limited in creditors' voluntary liquidation?
Last verified 5 June 2026
Yes, Eagle Genomics Limited (company number 06587071) entered creditors' voluntary liquidation on 13 March 2025, by its creditors. Joseph Walter Colley of null was appointed as liquidator.
Do you deal with companies like Eagle Genomics Limited? Add up to 5 companies free. We'll email you the day one enters administration.
Free, no card. We'll send a one-click sign-in link, no password to remember.
Prefer the earlier signs? Protect catches the pattern that builds, well before it's official. See how it works →
Eagle Genomics Limited is now in creditors' voluntary liquidation. Below are the key dates, the directors, the public-record timeline that led here, and what the liquidation means if you are a creditor, employee, customer or supplier.
How the case progressed
Administration
4 April 2024 · CBW Recovery LLP
Creditors' voluntary liquidation
13 March 2025
Company at a glance
| Status | In Creditors' Voluntary Liquidation |
|---|
| Company number | 06587071 |
|---|
| Incorporated | 7 May 2008 (18 years old) |
|---|
| Registered office | 6th Floor 9 Appold Street, London, EC2A 2AP |
|---|
| Nature of business (SIC) | 62012: Business and domestic software development (IT & managed services) |
|---|
| Date entered creditors' voluntary liquidation | 13 March 2025 |
|---|
| Liquidator | Joseph Walter Colley, null (licensed insolvency practitioner) |
|---|
| Official notice | View the official notice ↗ |
|---|
| Statement of Affairs | Filed 25 June 2024, declared assets & liabilities ↗ |
|---|
| Public register | View filing history ↗ |
|---|
About the business
Eagle Genomics Limited is a it & managed services business based in London, incorporated in 2008 and 17 years old when the liquidator was appointed. Its registered activity is business and domestic software development (SIC 62012). There have been 24 director appointments since incorporation, of which 6 were on the board when the liquidator was appointed, alongside 1 person with significant control.
Directors
24 people have been appointed as directors of Eagle Genomics Limited.
DirectorStatusAppointedResigned
+18 former directors · resigned 2009 to 2024
A director resignation shortly before an insolvency is a matter of public record; it does not by itself imply wrongdoing.
Persons with significant control
Individuals or entities with significant influence or control.
Etf Partners Llp (Acting As Manager Of Environmental Technologies Fund 3 Lp)
corporate entity person with significant control
Ownership of shares 25-50%Voting rights 25-50%
What happened
EventDateType
Liquidators' statement of receipts and payments18 May 2026LIQ03
Registered office address changed from 10 Lower Thames Street London EC3R 6AF to 6th Floor 9 Appold Street London EC2A 2AP on 2025-12-1616 December 2025AD01 Appointment of a voluntary liquidator20 March 2025600
Notice of move from Administration case to Creditors Voluntary Liquidation13 March 2025AM22 Notice of administrator's death13 February 2025AM18
+169 earlier events · 2008 to 2024
Administrator's progress report23 October 2024AM10 Statement of affairs with form AM02SOA/AM02SOC25 June 2024AM02 Result of meeting of creditors4 June 2024AM07
Statement of administrator's proposal18 May 2024AM03 Registered office address changed from Biodata Innovation Centre Wellcome Genome Campus Hinxton Cambridge Cambridgeshire CB10 1DR England to 10 Lower Thames Street London EC3R 6AF on 2024-04-044 April 2024AD01 Appointment of an administrator4 April 2024AM01 Termination of appointment of John Schoellerman as a director on 2024-02-0823 February 2024TM01 Amended accounts for a small company made up to 2021-03-317 February 2024AAMD Amended accounts for a small company made up to 2020-03-317 February 2024AAMD Statement of capital following an allotment of shares on 2023-12-2127 December 2023SH01 Statement of capital following an allotment of shares on 2023-10-1119 October 2023SH01 Particulars of variation of rights attached to shares12 October 2023SH10 Change of share class name or designation10 October 2023SH08 Memorandum and Articles of Association10 October 2023MA Appointment of Mr John Schoellerman as a director on 2023-09-275 October 2023AP01 Statement of capital following an allotment of shares on 2023-10-044 October 2023SH01 Appointment of Mr Nigel Higgs as a secretary on 2023-09-274 October 2023AP03 Appointment of Dr Victoria Kimonides as a director on 2023-09-274 October 2023AP01 Termination of appointment of Anthony Charles Finbow as a director on 2023-09-274 October 2023TM01 Termination of appointment of Gavin Alan Horn as a secretary on 2023-09-274 October 2023TM02 Termination of appointment of Clifford Bennett Meltzer as a director on 2023-09-274 October 2023TM01 Confirmation statement made on 2023-07-12 with updates26 July 2023CS01 Total exemption full accounts made up to 2022-03-316 April 2023AA Total exemption full accounts made up to 2021-03-319 March 2023AA Total exemption full accounts made up to 2020-03-319 March 2023AA Statement of capital following an allotment of shares on 2022-12-3016 January 2023SH01 Memorandum and Articles of Association30 December 2022MA Compulsory strike-off action has been discontinued29 November 2022DISS40 First Gazette notice for compulsory strike-off22 November 2022GAZ1 Memorandum and Articles of Association14 November 2022MA Appointment of Mr Alistair Watson as a director on 2022-10-2814 November 2022AP01 Statement of capital following an allotment of shares on 2022-10-2814 November 2022SH01 Second filing of a statement of capital following an allotment of shares on 2022-07-1315 September 2022RP04SH01 Statement of capital following an allotment of shares on 2022-07-1323 August 2022SH01 Confirmation statement made on 2022-07-12 with updates12 July 2022CS01 Compulsory strike-off action has been discontinued1 June 2022DISS40 First Gazette notice for compulsory strike-off31 May 2022GAZ1 Confirmation statement made on 2022-05-07 with no updates26 May 2022CS01 Confirmation statement made on 2021-05-07 with updates25 May 2021CS01 Memorandum and Articles of Association23 October 2020MA Termination of appointment of Simon Charles Thorpe as a director on 2020-09-1022 October 2020TM01 Appointment of Miklós Kóbor as a director on 2020-09-1022 October 2020AP01 Statement of capital following an allotment of shares on 2020-10-0822 October 2020SH01 Confirmation statement made on 2020-05-07 with updates19 May 2020CS01 Statement of capital following an allotment of shares on 2020-01-2030 March 2020SH01 Accounts for a small company made up to 2019-03-312 January 2020AA Appointment of Ms Delphine Gény-Stephann as a director on 2019-12-035 December 2019AP01 Statement of capital following an allotment of shares on 2019-03-2016 May 2019SH01 Confirmation statement made on 2019-05-07 with updates16 May 2019CS01 Notification of Etf Partners Llp (Acting as Manager of Environmental Technologies Fund 3 Lp) as a person with significant control on 2019-01-2214 February 2019PSC02 Withdrawal of a person with significant control statement on 2019-02-1313 February 2019PSC09 Statement of capital following an allotment of shares on 2019-01-2212 February 2019SH01 Change of share class name or designation12 February 2019SH08 Particulars of variation of rights attached to shares12 February 2019SH10 Appointment of Mr Werner Robert Genieser as a director on 2019-01-2225 January 2019AP01 Termination of appointment of Abel Javier Ureta-Vidal as a director on 2019-01-2225 January 2019TM01 Termination of appointment of Vernon Harten-Ash as a director on 2019-01-2225 January 2019TM01 Termination of appointment of Andrew Victor Graham Muir as a director on 2019-01-2225 January 2019TM01 Accounts for a small company made up to 2018-03-3114 September 2018AA Statement of capital following an allotment of shares on 2018-06-2025 June 2018SH01 Termination of appointment of Christopher Patrick O'connor as a secretary on 2018-06-0613 June 2018TM02 Appointment of Mr Gavin Alan Horn as a secretary on 2018-06-0613 June 2018AP03 Confirmation statement made on 2018-05-07 with updates15 May 2018CS01 Appointment of Mr Simon Charles Thorpe as a director on 2018-03-284 May 2018AP01 Statement of capital following an allotment of shares on 2018-03-293 May 2018SH01 Notification of a person with significant control statement26 March 2018PSC08 Withdrawal of a person with significant control statement on 2018-03-2626 March 2018PSC09 Memorandum and Articles of Association13 March 2018MA Statement of capital following an allotment of shares on 2018-02-225 March 2018SH01 Appointment of Mr Clifford Bennett Meltzer as a director on 2017-09-0618 October 2017AP01 Termination of appointment of William Hugo Spooner as a director on 2017-09-0611 October 2017TM01 Accounts for a small company made up to 2017-03-3129 June 2017AA Termination of appointment of Alan Walter Barrell as a director on 2017-06-0713 June 2017TM01 Confirmation statement made on 2017-05-07 with updates19 May 2017CS01 Statement of capital following an allotment of shares on 2017-02-1727 March 2017SH01 Statement of capital following an allotment of shares on 2016-10-1822 January 2017SH01 Statement of capital following an allotment of shares on 2016-12-2322 January 2017SH01 Registered office address changed from Biodata Innovation Centre Biodata Innovation Centre Wellcome Genome Campus, Hinxton Cambridge Cambridgeshire CB10 1DR England to Biodata Innovation Centre Wellcome Genome Campus Hinxton Cambridge Cambridgeshire CB10 1DR on 2016-11-1616 November 2016AD01 Registered office address changed from Babraham Hall Babraham Research Campus Babraham Cambridgeshire CB22 3AT to Biodata Innovation Centre Biodata Innovation Centre Wellcome Genome Campus, Hinxton Cambridge Cambridgeshire CB10 1DR on 2016-11-1616 November 2016AD01 Full accounts made up to 2016-03-313 November 2016AA Annual return made up to 2016-05-07 with full list of shareholders29 June 2016AR01 Statement of capital following an allotment of shares on 2015-08-2419 May 2016SH01 Appointment of Dr Andrew Victor Graham Muir as a director on 2015-12-1510 March 2016AP01 Appointment of Mr Anthony Charles Finbow as a director on 2016-01-269 March 2016AP01 Termination of appointment of Clive Austin as a director on 2015-12-1521 December 2015TM01 Full accounts made up to 2015-03-3118 December 2015AA Memorandum and Articles of Association28 August 2015MA Statement of capital following an allotment of shares on 2015-06-1527 July 2015SH01 Statement of capital on 2015-06-1227 July 2015SH02 Annual return made up to 2015-05-07 with full list of shareholders17 June 2015AR01 Full accounts made up to 2014-03-3121 October 2014AA Change of share class name or designation13 June 2014SH08 Annual return made up to 2014-05-07 with full list of shareholders29 May 2014AR01 Termination of appointment of Richard Holland as a director21 May 2014TM01 Statement of capital following an allotment of shares on 2014-02-2711 April 2014SH01 Termination of appointment of David Flanders as a director25 February 2014TM01 Appointment of Mr Christopher Patrick O'connor as a secretary7 February 2014AP03 Termination of appointment of Bcs Cosec Limited as a secretary7 February 2014TM02 Statement of capital following an allotment of shares on 2013-11-206 January 2014SH01 Full accounts made up to 2013-03-3116 December 2013AA Statement of capital following an allotment of shares on 2013-08-289 October 2013SH01 Appointment of Mr Clive Austin as a director26 September 2013AP01 Director's details changed for Dr Abel Javier Ureta-Vidal on 2013-06-0311 June 2013CH01 Director's details changed for Sir Alan Walter Barrell on 2013-06-0311 June 2013CH01 Director's details changed for Richard Charles Geoffrey Holland on 2013-06-0311 June 2013CH01 Director's details changed for Dr William Hugo Spooner on 2013-06-0311 June 2013CH01 Annual return made up to 2013-05-07 with full list of shareholders7 May 2013AR01 Director's details changed for Dr Abel Javier Ureta-Vidal on 2013-05-077 May 2013CH01 Director's details changed for Richard Charles Geoffrey Holland on 2013-05-077 May 2013CH01 Director's details changed for Dr William Hugo Spooner on 2013-05-077 May 2013CH01 Full accounts made up to 2012-03-3120 November 2012AA Appointment of Bcs Cosec Limited as a secretary26 July 2012AP04 Termination of appointment of Legalsurf Registrars Limited as a secretary26 July 2012TM02 Registered office address changed from Legal Surfing Centre St. Andrews House 90 St. Andrews Road Cambridge Cambridgeshire CB4 1DL on 2012-06-011 June 2012AD01 Annual return made up to 2012-05-07 with full list of shareholders1 June 2012AR01 Termination of appointment of David O'farrell as a director28 March 2012TM01 Appointment of Mr David John Flanders as a director16 September 2011AP01 Director's details changed for Dr Vernon Harten-Ash on 2011-08-2424 August 2011CH01 Director's details changed for Professor Alan Walter Barrell on 2011-08-2424 August 2011CH01 Director's details changed for Richard Charles Geoffrey Holland on 2011-08-2424 August 2011CH01 Director's details changed for Dr Abel Javier Ureta-Vidal on 2011-08-2424 August 2011CH01 Director's details changed for Dr William Hugo Spooner on 2011-08-2424 August 2011CH01 Director's details changed for Mr David John O'farrell on 2011-08-2424 August 2011CH01 Total exemption small company accounts made up to 2011-03-3111 August 2011AA Annual return made up to 2011-05-07 with full list of shareholders25 May 2011AR01 Total exemption small company accounts made up to 2010-03-317 December 2010AA Director's details changed for Mr David John O'farrell on 2010-11-1919 November 2010CH01 Annual return made up to 2010-05-07 with full list of shareholders20 May 2010AR01 Director's details changed for Dr Abel-Javier Ureta-Vidal on 2010-05-0620 May 2010CH01 Director's details changed for Richard Charles Geoffrey Holland on 2010-05-0619 May 2010CH01 Director's details changed for Dr William Hugo Spooner on 2010-05-0619 May 2010CH01 Registered office address changed from St Andrews House 90 St Andrews Road Cambridge Cambridgeshire CB4 1DL on 2010-01-2727 January 2010AD01 Statement of capital following an allotment of shares on 2009-11-1923 December 2009SH01 Memorandum and Articles of Association11 December 2009MEM/ARTS
Total exemption small company accounts made up to 2009-03-315 October 2009AA Legacy4 February 2009288a Legacy6 November 2008288a Legacy6 November 2008288a Legacy23 October 200888(2) What this means for you
If you are a creditor
Submit your proof of debt to the liquidator. Once liquidation begins, no creditor can start or continue legal action without the court's permission. Unsecured creditors rank after secured and preferential creditors and are usually paid last, often only a portion.
Owed money by a company in liquidation →If you are an employee
Employees are preferential creditors for certain unpaid wages and holiday pay, and may be able to claim from the Redundancy Payments Service if roles are made redundant.
Employee rights and redundancy pay →If you are a customer
Deposits paid are usually unsecured claims. Contracts may be terminated by the liquidator. Contact the liquidator about outstanding work or refunds.
What customers can recover →If you are a supplier
Goods supplied before the liquidation began are an unsecured claim. Check whether any retention-of-title clause lets you identify and recover specific goods.
How retention of title works →Don't be the last to know next time
Most suppliers only find out a customer has failed once it is announced. By then it is too late. Protect monitors every company you sell to and emails you as the warning signs build, well before it becomes official. We can't stop a customer failing, but you'll never be the last to know, and you'll know you did all you could.
See how Protect works, £24/mo →Other it & managed services companies in creditors' voluntary liquidation
Related guides
The bigger picture
Frequently asked questions
- Is Eagle Genomics Limited in creditors' voluntary liquidation?
- Yes. Eagle Genomics Limited (company number 06587071) entered creditors' voluntary liquidation on 13 March 2025, by its creditors. Joseph Walter Colley of null was appointed as liquidator.
- Who is the liquidator of Eagle Genomics Limited?
- Joseph Walter Colley, a licensed insolvency practitioner at null, was appointed liquidator of Eagle Genomics Limited on 13 March 2025. Creditors can contact the liquidator directly to submit a claim.
- What does Eagle Genomics Limited do?
- Eagle Genomics Limited's registered nature of business is business and domestic software development (SIC 62012). It is classified in the it & managed services sector.
- Where is Eagle Genomics Limited based?
- Eagle Genomics Limited's registered office is 6th Floor 9 Appold Street, London, EC2A 2AP. The registered office is the address held on the public register, which is not always the trading address.
- When was Eagle Genomics Limited founded?
- Eagle Genomics Limited was incorporated on 7 May 2008, 17 years before the liquidator was appointed.
- What is Eagle Genomics Limited's company number?
- Eagle Genomics Limited's registered company number is 06587071.
- Who has significant control of Eagle Genomics Limited?
- 1 active person with significant control over Eagle Genomics Limited is on the register: Etf Partners Llp (Acting As Manager Of Environmental Technologies Fund 3 Lp).
- What does liquidation mean for creditors of Eagle Genomics Limited?
- Liquidation is the formal wind-up of a company. Once it begins, the liquidator collects assets, settles claims in statutory order (secured, preferential, then unsecured) and distributes whatever remains. Unsecured creditors often recover only a portion of what they are owed, and sometimes nothing.
- How long does liquidation take?
- Most liquidations run for 12 to 24 months, longer where the company has complex assets, litigation, or ongoing trading. Annual progress reports are filed by the liquidator until the company is dissolved at the end of the process.
- Will creditors get paid in Eagle Genomics Limited's liquidation?
- Secured creditors are paid from the assets they hold a charge over. Preferential creditors (employee wages up to limits, pension contributions, HMRC for certain taxes) come next. Unsecured creditors share whatever remains, which may be nothing. The Statement of Affairs, when filed, sets out the liquidator's estimate at the point of appointment.
Report an error on this page·Not financial, credit or legal advice.